China · Investor

Huagai Capital

Last cheque observed Jul 2026; 75 cheques on record.

Deploying nowPrivate equity

BuyoutGrowthSeedHealthcareTechnology

Deploying now
63%of best year5cheques in 12 months, 75 on record
Since the last cheque117days00hrs00min00sec
Median round$15MRounds led1 of 75Sole investor30 roundsMostly inUnited States, 60%
Pitch Huagai Capital

Huagai Capital highlights

  1. 01

    5 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 66% of its rounds

  3. 03

    Sole investor in 30 rounds, median $3.1M

What they do

Huagai Capital was founded in 2012, a private equity investment institution co-founded by a group of professionals from well-known domestic and international investment institutions in the industry.Translated from Chinese, from their own website
Type
Private equity
Cheque size
Not stated
Stages
BuyoutGrowthSeedSeries A
Sectors
HealthcareTechnology
Based in
China
Cold pitches
Not stated

The record

Every round we can evidence, newest first75 appearances

  1. 2026

    5 rounds

  2. Jul
    SeaArtSeries B · HK$15MWith 3 others
  3. Mar
    PrinoPharmaPre-seed$15MSole investor
  4. Feb
    ChromaiVentureUndisclosedSole investor
  5. Feb
    Bluesail SurgicalVentureUndisclosedSole investor
  6. Jan
    PAQ TherapeuticsSeries B · US$38MWith 2 others
  7. 2025

    4 rounds

  8. Oct
    Hyperway PharmSeries B$28MSole investor
  9. Aug
    Moyang BiotechnologyVentureUndisclosedSole investor
  10. Aug
    Leaf BiotechSeries B$14MSole investor
  11. Jan
    Alebund PharmaceuticalsSeries C$75MWith 2 others
  12. 2024

    2 rounds

  13. Dec
    uBriGeneSeries D$27MWith 3 others
  14. Jan
    Chuanxin BiotechVentureUndisclosedSole investor
  15. 2023

    9 rounds

  16. Nov
    Argo BiopharmaSeries A$41MWith 2 others
  17. Nov
    MobiDropVentureUndisclosedWith 1 other
  18. Aug
    Jinfang PharmaceuticalVentureUndisclosedWith 3 others
  19. Jul
    SinglomicsVenture$1.4MWith 2 others
  20. Jul
    MindRank AISeries A$23MWith 2 others
  21. Jun
    Innolake BiopharmSeries A$14MWith 1 other
  22. Feb
    LIBAOTEVentureUndisclosedSole investor
  23. Feb
    Beeplus Co-working SpaceVentureUndisclosedSole investor
  24. Feb
    Reliable MedSeries A$15MWith 1 other
  25. 2022

    4 rounds

  26. Oct
    Carmine TherapeuticsSeries A · US · Firms' own news pagesUndisclosedWith 3 others
  27. Jul
    H.ExtractVentureUndisclosedWith 1 other
  28. Jun
    HuojianpaiVentureUndisclosedWith 1 other
  29. Feb
    ClounixSeries A$63MWith 1 other
  30. 2021

    10 rounds

  31. Dec
    Beijing Sudo TechnologySeries A$48MWith 3 others
  32. Dec
    Meike SolarSeries B$188MWith 2 others
  33. Dec
    Quantinfo TechnologySeries B$3.1MWith 1 other
  34. Dec
    InCareySeries C$31MWith 2 others
  35. Nov
    NeuraMatrixSeries A$16MWith 1 other
  36. Aug
    JOINN BiologicsSeries B · US$150MWith 1 other
  37. Jul
    XianghuanjiSeries B$8.5MSole investor
  38. Jun
    GensKeySeries C$16MWith 2 others
  39. May
    Duality BiologicsSeries B$90MWith 3 others
  40. Jan
    Pin Hu TangGrowth$1.9MWith 1 other
  41. 2020

    4 rounds

  42. Jul
    Haihe BiopharmaSeries B$171MWith 3 others
  43. Jul
    AccuMedicalSeries B$14MWith 1 other
  44. May
    MGI TechSeries B$1.0BWith 4 others
  45. Mar
    Tongcheng Bills NetworkSeries B$21MWith 2 others
  46. 2019

    9 rounds

  47. Nov
    Genome WisdomSeries B · CN · 36Kr$8.5MWith 1 other
  48. Aug
    OmescapeSeries A$5.7MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Huagai Capital. A count of rooms they were both in, not a relationship either has claimed.

Green Pine CapitalVC firm6rounds togetherIDG CapitalPrivate equity6rounds togetherLegend CapitalVC firm5rounds togetherMatrix Partners ChinaVC firm4rounds togetherHSGVC firm3rounds togetherSherpa Healthcare PartnersVC firm3rounds togetherTengxun TouziVC firm3rounds togetherZhenFundVC firm3rounds togetherAddor CapitalVC firm2rounds togetherCDH InvestmentsPrivate equity2rounds togetherChina Growth CapitalVC firm2rounds togetherChina Merchants CapitalVC firm2rounds together

Recently backed

The latest companies Huagai Capital put money into.

SeaArt$15M · Jul 2026Bluesail SurgicalFeb 2026PAQ Therapeutics$38M · Jan 2026Alebund Pharmaceuticals$75M · Jan 2025Argo Biopharma$41M · Nov 2023Singlomics$1.4M · Jul 2023

Quick answers about Huagai Capital

What does Huagai Capital invest in?

Huagai Capital invests most often at Series A and Series B (66% of the rounds on record), in sectors such as Healthcare and Technology.

How active is Huagai Capital?

75 investments on record, 5 of them in the last 12 months, and it led 1. The most recent was in Jul 2026.

What has Huagai Capital invested in recently?

Its most recent investments on record: SeaArt (Series B, Jul 2026), PrinoPharma (Pre-seed, Mar 2026) and Chromai (Venture, Feb 2026).

How big are Huagai Capital's cheques?

The median round it joins is $15M.

Does Huagai Capital lead rounds?

Sometimes: it led 1 of its 75 investments on record (1%).

Where does Huagai Capital invest?

Most of the companies it backs are in the United States (60%), Hong Kong SAR China (20%) and China (20%).

Is Huagai Capital investing now?

Yes: it is actively investing, with 5 investments in the last 12 months.

Who does Huagai Capital invest alongside?

Most often Green Pine Capital (6 rounds together), IDG Capital (6 rounds together) and Legend Capital (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it